PTC Therapeutics, Inc. (PTCT): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$12.13M
Year ended 2019-12-31
$12.67M2015-12-31: $02016-12-31: $02017-12-31: $4.58M2018-12-31: $12.67M2019-12-31: $12.13M$12.13M
2015-12-31 Cost of Revenue (USD) 2019-12-31
Period endedCost of RevenueChange YoYSource filing
2019-12-31$12.13M-4.2%2020-03-02, From 2019-01-01
2018-12-31$12.67M+176.8%2020-03-02, From 2018-01-01
2017-12-31$4.58Mn/a2020-03-02, From 2017-01-01
2016-12-31$0n/a2018-03-06, From 2016-01-01
2015-12-31$0n/a2018-03-06, From 2015-01-01